{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:04:47Z","timestamp":1765807487652,"version":"3.44.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI101153","2R01AI059638"],"award-info":[{"award-number":["1R01AI101153","2R01AI059638"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.cellimm.2017.09.008","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T02:32:18Z","timestamp":1506047538000},"page":"41-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NF\u03baB and AP-1 transcription"],"prefix":"10.1016","volume":"322","author":[{"given":"Jamie Josephine Avila","family":"McLeod","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather L.","family":"Caslin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Spence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M.","family":"Kolawole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina Abdul","family":"Qayum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuya","family":"Paranjape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Taruselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara T.","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasalina N.","family":"Kiwanuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard L.","family":"Elford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2017.09.008_b0005","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/ni.f.216","article-title":"New developments in mast cell biology","volume":"9","author":"Kalesnikoff","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.rmed.2011.09.007","article-title":"The role of mast cells in allergic inflammation","volume":"106","author":"Amin","year":"2012","journal-title":"Respir. Med."},{"key":"10.1016\/j.cellimm.2017.09.008_b0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-065X.2011.01024.x","article-title":"Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases","volume":"242","author":"Burton","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2017.09.008_b0020","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0952-7915(05)80005-6","article-title":"Cytokine production by mast cells and basophils","volume":"3","author":"Galli","year":"1991","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0025","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaci.2007.07.033","article-title":"Anaphylaxis: lessons from mouse models","volume":"120","author":"Finkelman","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0030","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaci.2009.08.035","article-title":"Mechanisms of mast cell signaling in anaphylaxis","volume":"124","author":"Metcalfe","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0035","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.4049\/jimmunol.1003574","article-title":"Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis","volume":"186","author":"Sayed","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0040","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1126\/science.1073176","article-title":"Mast cells: a cellular link between autoantibodies and inflammatory arthritis","volume":"297","author":"Lee","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cellimm.2017.09.008_b0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1601","article-title":"Mast cells promote atherosclerosis by releasing proinflammatory cytokines","volume":"13","author":"Sun","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2017.09.008_b0050","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.191.5.813","article-title":"Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis","volume":"191","author":"Secor","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2017.09.008_b0055","first-page":"844","article-title":"New ribonucleotide reductase inhibitors with antineoplastic activity","volume":"39","author":"Elford","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2017.09.008_b0060","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4161\/cbt.1.5.174","article-title":"Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3","volume":"1","author":"Inayat","year":"2002","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.cellimm.2017.09.008_b0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1212\/01.WNL.0000042048.85204.3D","article-title":"Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants","volume":"60","author":"Turchan","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.cellimm.2017.09.008_b0070","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/bjc.1990.98","article-title":"A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The cancer research campaign phase I\/II clinical trials committee","volume":"61","author":"Carmichael","year":"1990","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cellimm.2017.09.008_b0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2141.2006.06261.x","article-title":"Didox, a ribonucleotide reductase inhibitor, induces apoptosis and inhibits DNA repair in multiple myeloma cells","volume":"135","author":"Raje","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0080","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/bjc.1991.488","article-title":"Phase II trial of didox in advanced breast cancer. Cancer research campaign phase I\/II clinical trials committee","volume":"64","author":"Rubens","year":"1991","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.cellimm.2017.09.008_b0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-9255-7-43","article-title":"Inhibition of allogeneic inflammatory responses by the ribonucleotide reductase inhibitors, didox and trimidox","volume":"7","author":"Inayat","year":"2010","journal-title":"J. Inflamm. (Lond.)"},{"key":"10.1016\/j.cellimm.2017.09.008_b0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cbi.2015.03.027","article-title":"3,4-Dihydroxy-benzohydroxamic acid (Didox) suppresses pro-inflammatory profiles and oxidative stress in TLR4-activated RAW264.7 murine macrophages","volume":"233","author":"Matsebatlela","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cellimm.2017.09.008_b0095","first-page":"1","article-title":"Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells","author":"Caslin","year":"2017","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0100","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.4049\/jimmunol.1501932","article-title":"Fluvastatin suppresses mast cell and basophil ige responses: genotype-dependent effects","volume":"196","author":"Kolawole","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0105","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.4049\/jimmunol.1600651","article-title":"Lactic acid suppresses IL-33\u2013mediated mast cell inflammatory responses via hypoxia-inducible factor-1\u03b1\u2013dependent miR-155 suppression","volume":"197","author":"Abebayehu","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0110","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1189\/jlb.3A0316-125R","article-title":"Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity","volume":"100","author":"Paranjape","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0115","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.imbio.2015.05.005","article-title":"Recognition of Candida albicans by Dectin-1 induces mast cell activation","volume":"220","author":"Nieto-Patl\u00e1n","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.cellimm.2017.09.008_b0120","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fimmu.2012.00106","article-title":"Tetraspanins in mast cells","volume":"3","author":"K\u00f6berle","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.cr.7290301","article-title":"Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation","volume":"15","author":"Hennersdorf","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.cellimm.2017.09.008_b0130","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.4049\/jimmunol.1500665","article-title":"Differential roles of phospholipase D proteins in Fc\u03b5RI-mediated signaling and mast cell function","volume":"195","author":"Zhu","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0135","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.4049\/jimmunol.1202723","article-title":"Genotype-dependent effects of TGF-\u03b21 on mast cell function: targeting the Stat5 pathway","volume":"191","author":"Fernando","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2006.01.001","article-title":"Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells","volume":"245","author":"Madlener","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellimm.2017.09.008_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2011.09.030","article-title":"Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations","volume":"52","author":"Kalyanaraman","year":"2012","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.cellimm.2017.09.008_b0150","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0899-9007(96)00000-8","article-title":"Inflammation, free radicals, and antioxidants","volume":"12","author":"Conner","year":"1996","journal-title":"Nutrition"},{"key":"10.1016\/j.cellimm.2017.09.008_b0155","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1067\/mai.2000.104942","article-title":"Dependence of mast cell IgE-mediated cytokine production on nuclear factor-kappaB activity","volume":"105","author":"Marquardt","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0065-2776(01)76022-1","article-title":"Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function","volume":"76","author":"Nadler","year":"2000","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0165","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1067\/mai.2003.1342","article-title":"Role of activator protein 1, nuclear factor-\u03baB, and nuclear factor of activated T cells in IgE receptor-mediated cytokine expression in mature human mast cells","volume":"111","author":"Lorentz","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0170","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1067\/mai.2002.123302","article-title":"Pathways of anaphylaxis in the mouse","volume":"109","author":"Strait","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0175","series-title":"Chemical Immunology and Allergy","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000315937","article-title":"Anaphylaxis: mechanisms of mast cell activation","author":"Kalesnikoff","year":"2010"},{"key":"10.1016\/j.cellimm.2017.09.008_b0180","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2003.11.007","article-title":"In vivo examination of hydroxyurea and the novel ribonucleotide reductase inhibitors trimidox and didox in combination with the reverse transcriptase inhibitor abacavir: suppression of retrovirus-induced immunodeficiency disease","volume":"62","author":"Sumpter","year":"2004","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cellimm.2017.09.008_b0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/bjc.1988.164","article-title":"A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitor","volume":"58","author":"Veale","year":"1988","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.cellimm.2017.09.008_b0190","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0065-2571(81)90014-5","article-title":"Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agents","volume":"19","author":"Elford","year":"1980","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.cellimm.2017.09.008_b0195","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1021\/jm00191a027","article-title":"Synthesis of hydroxy- and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activity","volume":"22","author":"van't Riet","year":"1979","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellimm.2017.09.008_b0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1749-6632.2010.05864.x","article-title":"Chemopreventive effects of resveratrol and resveratrol derivatives","volume":"1215","author":"Szekeres","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cellimm.2017.09.008_b0205","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/S0024-3205(97)00925-9","article-title":"Iron binding capacity of Didox (3,4-Dihydroxybenzohydroxamic acid) and Amidox (3,4-Dihydroxybenzamidoxime) new inhibitors of the enzyme ribonucleotide reductase","volume":"61","author":"Szekeres","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.cellimm.2017.09.008_b0210","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejphar.2013.08.009","article-title":"Didox potentiates the cytotoxic profile of doxorubicin and protects from its cardiotoxicity","volume":"718","author":"Al-Abd","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0215","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0737s90","article-title":"Generation, isolation, and maintenance of human mast cells and mast cell lines derived from peripheral blood or cord blood","author":"R\u00e5dinger","year":"2010","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/301850","article-title":"Proliferative tumor doubling times of prostatic carcinoma","volume":"2011","author":"Werahera","year":"2011","journal-title":"Prostate Cancer"},{"key":"10.1016\/j.cellimm.2017.09.008_b0225","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","article-title":"Proliferation, cell cycle and apoptosis in cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2017.09.008_b0230","doi-asserted-by":"crossref","unstructured":"L.B. Afrin, Utility of hydroxyurea in mast cell activation syndrome, 2 (2013) 1\u20131.","DOI":"10.1186\/2162-3619-2-28"},{"key":"10.1016\/j.cellimm.2017.09.008_b0235","first-page":"544","article-title":"Effectiveness and acceptance of hydroxyurea in the treatment of severe forms of sickle cell disease: a prospective study of 65 cases","volume":"91","author":"Mellouli","year":"2013","journal-title":"Tunis Med."},{"key":"10.1016\/j.cellimm.2017.09.008_b0240","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1476-5829.2010.00211.x","article-title":"Phase II open-label study of single-agent hydroxyurea for treatment of mast cell tumours in dogs","volume":"8","author":"Rassnick","year":"2010","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0245","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.20110367","article-title":"Mitochondrial reactive oxygen species drive proinflammatory cytokine production: Fig. 1","volume":"208","author":"Naik","year":"2011","journal-title":"J. Exp Med."},{"key":"10.1016\/j.cellimm.2017.09.008_b0250","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1134\/S000629791612018X","article-title":"Role of reactive oxygen species in mast cell degranulation","volume":"81","author":"Chelombitko","year":"2016","journal-title":"Biochem. Moscow"},{"key":"10.1016\/j.cellimm.2017.09.008_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/167014","article-title":"Propofol attenuates small intestinal ischemia reperfusion injury through inhibiting NADPH oxidase mediated mast cell activation","volume":"2015","author":"Gan","year":"2015","journal-title":"Oxid. Med. Cell. Longevity"},{"key":"10.1016\/j.cellimm.2017.09.008_b0260","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/eji.201444546","article-title":"Mast cell activation: a complex interplay of positive and negative signaling pathways","volume":"44","author":"Sibilano","year":"2014","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0265","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/viro.1997.8642","article-title":"Selective inhibition of l kappaB alpha phosphorylation and HIV-1 LTR-directed gene expression by novel antioxidant compounds","volume":"234","author":"Lee","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.cellimm.2017.09.008_b0270","doi-asserted-by":"crossref","first-page":"A65","DOI":"10.1016\/j.antiviral.2007.01.101","article-title":"The virtues of unique ribonucleotide reductase inhibitors didox and trimidox for retrovirus therapy","volume":"74","author":"Elford","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cellimm.2017.09.008_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2006.06.017","article-title":"Extending the nuclear roles of I\u03baB kinase subunits","author":"Gloire","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0280","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1046\/j.1471-4159.1999.0732501.x","article-title":"Activation of AP-1 and nuclear factor-kappaB transcription factors is involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes","volume":"73","author":"Vollgraf","year":"1999","journal-title":"J. Neurochem.."},{"key":"10.1016\/j.cellimm.2017.09.008_b0285","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.molimm.2014.06.008","article-title":"IgE in the absence of allergen induces the expression of monocyte chemoattractant protein-1 in the rat basophilic cell-line RBL-2H3","volume":"62","author":"Ahn","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0290","doi-asserted-by":"crossref","first-page":"31092","DOI":"10.1074\/jbc.272.49.31092","article-title":"Transcriptional regulation of the human monocyte chemoattractant protein-1 gene","volume":"272","author":"Ueda","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellimm.2017.09.008_b0295","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/intimm\/12.4.547","article-title":"Stimulation of FcgammaR receptors induces monocyte chemoattractant protein-1 in the human monocytic cell line THP-1 by a mechanism involving IkappaB-alpha degradation and formation of p50\/p65 NF-kappaB\/Rel complexes","volume":"12","author":"Alonso","year":"2000","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cellimm.2017.09.008_b0300","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1073\/pnas.121171998","article-title":"Unexpected signals in a system subject to kinetic proofreading","volume":"98","author":"Liu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cellimm.2017.09.008_b0305","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/31960","article-title":"Calcium oscillations increase the efficiency and specificity of gene expression","volume":"392","author":"Dolmetsch","year":"1998","journal-title":"Nature."},{"key":"10.1016\/j.cellimm.2017.09.008_b0310","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1476-4598-9-82","article-title":"Regulation of MCP-1 chemokine transcription by p53","volume":"9","author":"Hacke","year":"2010","journal-title":"Mol. Cancer."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874917301442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874917301442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:57:19Z","timestamp":1757804239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874917301442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":62,"alternative-id":["S0008874917301442"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2017.09.008","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NF\u03baB and AP-1 transcription","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2017.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}